Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer
Clinical trial NCT02984683 · TERMINATED
Trial details
- NCT number
- NCT02984683
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-23
- Primary completion
- 2018-09-07
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.